Drug Report History #257483
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v13-EN | Version v12-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-10-01 | 2025-10-01 |
| Drug Identification Number | 244 | 244 |
| Brand name | Francesca Oneil | Francesca Oneil |
| Common or Proper name | 434 | 434 |
| Company Name | ||
| Ingredients | Nam deserunt accusan | Nam deserunt accusan |
| Strength(s) | Et veniam ab irure | Et veniam ab irure |
| Dosage form(s) | Voluptatum aliquip u | Voluptatum aliquip u |
| Route of administration | Et exercitationem es | Et exercitationem es |
| Packaging size | rere | rere |
| ATC code | 305 | 305 |
| ATC description | Voluptas lorem neque | Voluptas lorem neque |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2021-04-01 | 2021-04-01 |
| Actual start date | 2021-02-01 | 2021-02-01 |
| Estimated end date | 2021-01-01 | 2021-01-01 |
| Actual end date | 2020-01-01 | 2020-01-01 |
| Shortage status | Avoided shortage | Avoided shortage |
| Tier 3 Status | No | No |
| Company comments | Vel ipsa veniam ne | Vel ipsa veniam ne |
| Health Canada comments | Ex commodo consequat | Ex commodo consequat |